{"count":7,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/55016381-95d5-4ae3-94d3-606d3499068a/","filing_uuid":"55016381-95d5-4ae3-94d3-606d3499068a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/55016381-95d5-4ae3-94d3-606d3499068a/print/","filing_document_content_type":"text/html","income":"21000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John Kevin Brennan","dt_posted":"2026-07-06T17:19:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"4620 Van Ness St, NW","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20016","registrant":{"id":401105447,"url":"https://lda.gov/api/v1/registrants/401105447/","house_registrant_id":null,"name":"BLUEBIRD STRATEGIES","description":"Consulting firm.","address_1":"4620 Van Ness St, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20016","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN KEVIN BRENNAN","contact_telephone":"+1 202-253-0924","dt_updated":"2026-07-07T11:45:17.907337-04:00"},"client":{"id":203728,"url":"https://lda.gov/api/v1/clients/203728/","client_id":48,"name":"THERMO FISHER SCIENTIFIC INC","general_description":"Scientific product and technology company.","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-11-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act PREEMPT Act (H.R. 9061) to promote the appropriate use of advanced preeclampsia biomarker testing as part of the Medicaid program. Seeking Senate companion legislation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72006,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"KEVIN","last_name":"BRENNAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/767d51f7-7f17-49a7-9be4-d19c4433eb1f/","filing_uuid":"767d51f7-7f17-49a7-9be4-d19c4433eb1f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/767d51f7-7f17-49a7-9be4-d19c4433eb1f/print/","filing_document_content_type":"text/html","income":null,"expenses":"280000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Timothy Fenton","dt_posted":"2026-07-13T14:43:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"168 Third Avenue","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Waltham","registrant_state":"MA","registrant_zip":"02454","registrant":{"id":323251,"url":"https://lda.gov/api/v1/registrants/323251/","house_registrant_id":39694,"name":"THERMO FISHER SCIENTIFIC INC.","description":"Scientific equipment, technologies and supplies","address_1":"168 Third Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Waltham","state":"MA","state_display":"Massachusetts","zip":"02454","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIA CHEN","contact_telephone":"+1 781-577-8405","dt_updated":"2026-07-10T16:09:57.974170-04:00"},"client":{"id":187246,"url":"https://lda.gov/api/v1/clients/187246/","client_id":12,"name":"THERMO FISHER SCIENTIFIC INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1899-12-30"},"lobbying_activities":[{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"General discussions regarding impact of U.S. federal government workforce changes on industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":65,"name":"General Services Administration (GSA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds. Regulation for Federal Financial Assistance (OMB-2026-0034).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"Preparedness products and services. General discussions around government contracting opportunities.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"POWER Act; all provisions of the bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, and other tax-related priorities.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c08a7dc9-62a4-4a09-b0d4-61ebfcf2115d/","filing_uuid":"c08a7dc9-62a4-4a09-b0d4-61ebfcf2115d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c08a7dc9-62a4-4a09-b0d4-61ebfcf2115d/print/","filing_document_content_type":"text/html","income":null,"expenses":"270000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Donald Horton, Jr.","dt_posted":"2026-07-14T14:58:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"531 South Spring Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Burlington","registrant_state":"NC","registrant_zip":"27215","registrant":{"id":401104793,"url":"https://lda.gov/api/v1/registrants/401104793/","house_registrant_id":null,"name":"LABORATORY CORPORATION OF AMERICA HOLDINGS","description":"Clinical laboratory and drug development services","address_1":"531 South Spring Street","address_2":null,"address_3":null,"address_4":null,"city":"Burlington","state":"NC","state_display":"North Carolina","zip":"27215","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DONALD E. HORTON, JR.","contact_telephone":"+1 336-213-4762","dt_updated":"2026-07-24T14:20:59.309615-04:00"},"client":{"id":202751,"url":"https://lda.gov/api/v1/clients/202751/","client_id":12,"name":"LABORATORY CORPORATION OF AMERICA HOLDINGS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NC","state_display":"North Carolina","country":"US","country_display":"United States of America","ppb_state":"NC","ppb_state_display":"North Carolina","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, and H.R. 9393, the Lower Costs, More Transparency Act, provisions relating to lab test price transparency; H.R. 8500, the Timely Access to Coverage Decisions Act, provisions relating to establishment of standards for Medicare local coverage decisions; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; H.R. 9061, the Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act, provisions relating to Medicaid coverage of preeclampsia screening tests; H.R. 8413, the Securing and Establishing Consumer Uniform Rights and Enforcement over Data (SECURE Data) Act, provisions relating to privacy of health care data; A draft of the AI Workforce Assessment and Research (AWARE) Act, provisions relating to disclosure of information on the use and impact of artificial intelligence in employment matters; A draft of the Great American AI Act, provisions relating to regulation of artificial intelligence; Federal policy relating to oversight of laboratory benefit managers; Federal policy relating to access to mandatory code sets for administrative transactions; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67936,"prefix":null,"prefix_display":null,"first_name":"DONALD","nickname":null,"middle_name":null,"last_name":"HORTON","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":67937,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"PREGEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Report language accompanying H.R. 8646, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027, provisions relating to oversight of laboratory-developed tests.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67936,"prefix":null,"prefix_display":null,"first_name":"DONALD","nickname":null,"middle_name":null,"last_name":"HORTON","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":67937,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"PREGEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/85aa44f6-9b05-46ad-b768-f3d43b394c46/","filing_uuid":"85aa44f6-9b05-46ad-b768-f3d43b394c46","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/85aa44f6-9b05-46ad-b768-f3d43b394c46/print/","filing_document_content_type":"text/html","income":null,"expenses":"60000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kenneth Hertz","dt_posted":"2026-07-20T12:31:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1550 Crystal Drive","registrant_address_2":"Suite 1300","registrant_different_address":true,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22202","registrant":{"id":23758,"url":"https://lda.gov/api/v1/registrants/23758/","house_registrant_id":30202,"name":"MARCH OF DIMES","description":null,"address_1":"1550 Crystal Drive","address_2":"Suite 1300","address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22202","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KENNETH HERTZ","contact_telephone":"+1 571-969-8655","dt_updated":"2026-07-20T11:44:00.324237-04:00"},"client":{"id":130997,"url":"https://lda.gov/api/v1/clients/130997/","client_id":12,"name":"MARCH OF DIMES","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Pregnancy nondiscrimination issues, implementation of Pregnancy Workers Fairness Act - monitoring only","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70662,"prefix":null,"prefix_display":null,"first_name":"KENNETH","nickname":null,"middle_name":"J.","last_name":"HERTZ","suffix":null,"suffix_display":null},"covered_position":"Rep. Louise M. Slaughter//Legislative Correspondent//Legislative Assistant","new":false},{"lobbyist":{"id":116663,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":"W.","last_name":"FULLERTON","suffix":null,"suffix_display":null},"covered_position":"Rep. Joe Sestak//Staff Assistant","new":false}],"government_entities":[{"id":50,"name":"Equal Employment Opportunity Commission (EEOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"No activity","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70662,"prefix":null,"prefix_display":null,"first_name":"KENNETH","nickname":null,"middle_name":"J.","last_name":"HERTZ","suffix":null,"suffix_display":null},"covered_position":"Rep. Louise M. Slaughter//Legislative Correspondent//Legislative Assistant","new":false},{"lobbyist":{"id":116663,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":"W.","last_name":"FULLERTON","suffix":null,"suffix_display":null},"covered_position":"Rep. Joe Sestak//Staff Assistant","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Protect Medicaid coverage for pregnant women, children, and infants. (HR 1, P.L. 119-21) Monitoring impacts post-enactment.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70662,"prefix":null,"prefix_display":null,"first_name":"KENNETH","nickname":null,"middle_name":"J.","last_name":"HERTZ","suffix":null,"suffix_display":null},"covered_position":"Rep. Louise M. Slaughter//Legislative Correspondent//Legislative Assistant","new":false},{"lobbyist":{"id":116663,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":"W.","last_name":"FULLERTON","suffix":null,"suffix_display":null},"covered_position":"Rep. Joe Sestak//Staff Assistant","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"No activity","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70662,"prefix":null,"prefix_display":null,"first_name":"KENNETH","nickname":null,"middle_name":"J.","last_name":"HERTZ","suffix":null,"suffix_display":null},"covered_position":"Rep. Louise M. Slaughter//Legislative Correspondent//Legislative Assistant","new":false},{"lobbyist":{"id":116663,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":"W.","last_name":"FULLERTON","suffix":null,"suffix_display":null},"covered_position":"Rep. Joe Sestak//Staff Assistant","new":false}],"government_entities":[]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2027 Budget and Appropriations for maternal and infant health programs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70662,"prefix":null,"prefix_display":null,"first_name":"KENNETH","nickname":null,"middle_name":"J.","last_name":"HERTZ","suffix":null,"suffix_display":null},"covered_position":"Rep. Louise M. Slaughter//Legislative Correspondent//Legislative Assistant","new":false},{"lobbyist":{"id":116663,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":"W.","last_name":"FULLERTON","suffix":null,"suffix_display":null},"covered_position":"Rep. Joe Sestak//Staff Assistant","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Maternal and infant health legislation: SHINE for Autumn Act (H.R. 5469, S.2858), NIH IMPROVE Act (H.R. 6238, S.3254), Healthy Start Reauthorization Act (H.R.3302, S.3799), Momnibus Act (H.R. 7973), Dads Matter Act (H.R. 5828, S. 2131), Rural Obstetrics Readiness Act (H.R. 1254, S. 380), and PREEMPT Act (H.R. 9061), legislation focused on coverage guidance on tests for the screening and early detection of preeclampsia.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70662,"prefix":null,"prefix_display":null,"first_name":"KENNETH","nickname":null,"middle_name":"J.","last_name":"HERTZ","suffix":null,"suffix_display":null},"covered_position":"Rep. Louise M. Slaughter//Legislative Correspondent//Legislative Assistant","new":false},{"lobbyist":{"id":116663,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":"W.","last_name":"FULLERTON","suffix":null,"suffix_display":null},"covered_position":"Rep. Joe Sestak//Staff Assistant","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Medicaid coverage for pregnant women, children, and infants. Monitoring rule-making and implementation of HR 1(Public Law No: 119-21)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70662,"prefix":null,"prefix_display":null,"first_name":"KENNETH","nickname":null,"middle_name":"J.","last_name":"HERTZ","suffix":null,"suffix_display":null},"covered_position":"Rep. Louise M. Slaughter//Legislative Correspondent//Legislative Assistant","new":false},{"lobbyist":{"id":116663,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":"W.","last_name":"FULLERTON","suffix":null,"suffix_display":null},"covered_position":"Rep. Joe Sestak//Staff Assistant","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"POS","general_issue_code_display":"Postal","description":"No activity","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70662,"prefix":null,"prefix_display":null,"first_name":"KENNETH","nickname":null,"middle_name":"J.","last_name":"HERTZ","suffix":null,"suffix_display":null},"covered_position":"Rep. Louise M. Slaughter//Legislative Correspondent//Legislative Assistant","new":false},{"lobbyist":{"id":116663,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":"W.","last_name":"FULLERTON","suffix":null,"suffix_display":null},"covered_position":"Rep. Joe Sestak//Staff Assistant","new":false}],"government_entities":[]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Special Supplemental Nutrition Program for Women, Infants, and Children (WIC)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70662,"prefix":null,"prefix_display":null,"first_name":"KENNETH","nickname":null,"middle_name":"J.","last_name":"HERTZ","suffix":null,"suffix_display":null},"covered_position":"Rep. Louise M. Slaughter//Legislative Correspondent//Legislative Assistant","new":false},{"lobbyist":{"id":116663,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":"W.","last_name":"FULLERTON","suffix":null,"suffix_display":null},"covered_position":"Rep. Joe Sestak//Staff Assistant","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Nonprofit tax and charitable giving. Advocated for preserving the Combined Federal Campaign (CFC)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70662,"prefix":null,"prefix_display":null,"first_name":"KENNETH","nickname":null,"middle_name":"J.","last_name":"HERTZ","suffix":null,"suffix_display":null},"covered_position":"Rep. Louise M. Slaughter//Legislative Correspondent//Legislative Assistant","new":false},{"lobbyist":{"id":116663,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":"W.","last_name":"FULLERTON","suffix":null,"suffix_display":null},"covered_position":"Rep. Joe Sestak//Staff Assistant","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":81,"name":"Office of Personnel Management (OPM)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/39b29a28-7315-46ec-aa84-87482a2a7adf/","filing_uuid":"39b29a28-7315-46ec-aa84-87482a2a7adf","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/39b29a28-7315-46ec-aa84-87482a2a7adf/print/","filing_document_content_type":"text/html","income":null,"expenses":"96000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kira Peterson","dt_posted":"2026-07-20T15:05:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"409 12th Street, SW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":400578740,"url":"https://lda.gov/api/v1/registrants/400578740/","house_registrant_id":null,"name":"AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS","description":"Medical Specialty Organization","address_1":"409 12th Street, SW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RACHEL TETLOW","contact_telephone":"+1 202-863-2534","dt_updated":"2026-07-30T10:48:37.231062-04:00"},"client":{"id":193054,"url":"https://lda.gov/api/v1/clients/193054/","client_id":12,"name":"AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-04-19"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Womens health research (general); Centers for Disease Control and Prevention (CDC); CDC Office on Smoking and Health; National Institutes of Health (NIH); NIH workforce training programs; National Center for Health Statistics; Division of Sexually Transmitted Disease Prevention; Agency for Healthcare Research and Quality (AHRQ); NIH Office of Research on Womens Health; Health Resources and Services Administration (HRSA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Safe Motherhood and Infant Health Program (CDC); IHS funding (general); National Center for Chronic Disease Prevention and Health Promotion (CDC); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC); inclusion of pregnant and lactating people in clinical trials (general); Congressionally Directed Medical Research Program (CDMRP); Title X family planning program; Title V Maternal and Child Health Block Grant; Title VII Health Professions and Title VIII Nursing Workforce Development programs; Pregnancy Risk Assessment Monitoring System (CDC); Teaching Health Center Graduate Medical Education Program (THCGME); Healthy Start; National Maternal Mental Health Hotline; maternal mental health programs; Alliance for Innovation on Maternal Health (AIM); stillbirth prevention; Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET); firearm injury and prevention research; menopause education; Womens Reproductive Health Research (WRHR); National Center for Environmental Health; Center for Substance Abuse Treatment Pregnant and Postpartum Womens Residential Services Grant Program; State Pilot Program for Treatment for Pregnant and Postpartum Women (PPW-PLT); SPRANS; Teen Pregnancy Prevention Program; CDC newborn screening; ovarian cancer detection (general); NIH ECHO Program; Neglected Surgical Conditions; Pediatric Specialty Loan Repayment Program; Agency for Toxic Substances and Disease Registry; WIC; OMB Rule of Federal Financial Assistance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64197,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"TETLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"FY27 National Defense Authorization Act; IVF coverage for servicemembers and dependents (general)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 8651/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); implementation of P.L. 119-21, One Big, Beautiful Bill Act; implementation of Sec. 6501 of P.L. 119-75, Preventing Maternal Deaths Reauthorization Act; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 7973, Momnibus Act; H.R. 7830, WELLS Act; H.R.8159, Gynecologic Pain Management Study Act; H.R.8160, Premenstrual Dysphoric Disorder Awareness and Research Act; H.R. 9441, SAFE Training for OBGYNs Act; H.R. 9061, PREEMPT Act; H.Res. 1282, a resolution recognizing ACOGs 75th anniversary; H.R. 8358, Breast Cancer Research Stamp Reauthorization Act; S. Res. 710, a resolution recognizing Maternal Mental Health Day; H.R. 9090/S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act; H.Res. 1323, a resolution recognizing National Menstrual Health Awareness Month; H.R. 8500, Timely Access to Coverage Decisions Act; H.R. 7694, Gwenns Law; S. 4878, Reproductive Health Care Training Act; H.R. _____/S. _____, Right to IVF Act; S. 4494, America Cures Act; maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); childhood vaccine recommendations (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); inclusion of pregnant and lactating women in clinical trials (general); pregnancy exposure registries (general); NIH/NICHD womens health research (general); access to fertility services and treatments (general); Restorative Reproductive Medicine (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); S. 4550/H.R. 8807, Maternal Health Pandemic Response Act; United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general); acetaminophen use during pregnancy (general); SSRI use during pregnancy (general); Pregnancy Risk Assessment Monitoring System (PRAMS); Maternal Mortality Review Information Application (MMRIA); FACE Act implementation; Nexplanon REMS; chaperones during sensitive procedures (general); FDA regulation of flavored e-cigarettes (general); ORR policies regarding pregnant minors (general); breast cancer risk assessment (general).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64197,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"TETLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Treatment of pregnant and postpartum people in immigration detention (general); access to medical care in immigration detention (general); H.R. 1061/S. 455, Protecting Sensitive Locations Act; H-1B and J-1 visa delays/disruptions for physicians and trainees (general); H.R. 7961, H-1Bs for Physicians and the Healthcare Workforce Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Physician payment under Medicare (general); Medicare Physician Fee Schedule Efficiency Adjustment (general); Graduate medical education (general); S.1816/H.R. 3514, Improving Seniors Timely Access to Care Act of 2025; Prior authorization in Medicare (general); Medicaid (general); Physician payment under Medicaid (general); Medicaid work requirements (general); CMS billing and coding procedures (general); preserving postpartum Medicaid extension (general); implementation of P.L. 119-21, One Big, Beautiful Bill Act; telehealth (general); H.R. 7520, Efficiency Adjustment Delay Act; H.R. 8163, Provider Reimbursement Stability Act; FMAP for Puerto Rico; unbundling of obstetric codes in Medicare","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64197,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"TETLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":76425,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"SATTERFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139300,"prefix":"ms","prefix_display":"MS.","first_name":"TAYLOR","nickname":null,"middle_name":null,"last_name":"PLATT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142986,"prefix":"mrs","prefix_display":"MRS.","first_name":"ERIN","nickname":null,"middle_name":"LAMBIE","last_name":"ALSTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"H.R. 8582/S. 4436, Protecting Human Rights and Public Health in Foreign Assistance Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Abortion access at the VA (general); H.R. 7841, Warrior Infertility Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/f8d4fc5a-9066-47da-a080-4d78ca3dd010/","filing_uuid":"f8d4fc5a-9066-47da-a080-4d78ca3dd010","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/f8d4fc5a-9066-47da-a080-4d78ca3dd010/print/","filing_document_content_type":"text/html","income":null,"expenses":"550000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Timothy Fenton","dt_posted":"2026-10-15T15:09:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"168 Third Avenue","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Waltham","registrant_state":"MA","registrant_zip":"02454","registrant":{"id":323251,"url":"https://lda.gov/api/v1/registrants/323251/","house_registrant_id":39694,"name":"THERMO FISHER SCIENTIFIC INC.","description":"Scientific equipment, technologies and supplies","address_1":"168 Third Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Waltham","state":"MA","state_display":"Massachusetts","zip":"02454","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIA CHEN","contact_telephone":"+1 781-577-8405","dt_updated":"2026-07-10T16:09:57.974170-04:00"},"client":{"id":187246,"url":"https://lda.gov/api/v1/clients/187246/","client_id":12,"name":"THERMO FISHER SCIENTIFIC INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1899-12-30"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, and other tax-related priorities. H.R. 9438 - Supporting Knowledge through Industry-Led Learning (SKILL) Act - all provisions of the bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"General discussions regarding regulatory and permitting considerations for power generation technologies and emissions monitoring.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":49,"name":"Environmental Protection Agency (EPA)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds. Regulation for Federal Financial Assistance (OMB-2026-0034). 2027 Public Law No: 119-103 - Continuing Appropriations and Extensions Act - all provisions of the bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"Preparedness products and services. General discussions around government contracting opportunities.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"POWER Act; all provisions of the bill.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147741,"prefix":null,"prefix_display":null,"first_name":"KEN","nickname":null,"middle_name":null,"last_name":"MONAHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":96029,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FISHMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151759,"prefix":null,"prefix_display":null,"first_name":"JENNA","nickname":null,"middle_name":null,"last_name":"CARMEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/982cee2a-8005-4ab9-bb71-324971d44fcb/","filing_uuid":"982cee2a-8005-4ab9-bb71-324971d44fcb","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/982cee2a-8005-4ab9-bb71-324971d44fcb/print/","filing_document_content_type":"text/html","income":"21000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John Kevin Brennan","dt_posted":"2026-10-16T16:06:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"4620 Van Ness St, NW","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20016","registrant":{"id":401105447,"url":"https://lda.gov/api/v1/registrants/401105447/","house_registrant_id":null,"name":"BLUEBIRD STRATEGIES","description":"Consulting firm.","address_1":"4620 Van Ness St, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20016","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN KEVIN BRENNAN","contact_telephone":"+1 202-253-0924","dt_updated":"2026-07-07T11:45:17.907337-04:00"},"client":{"id":203728,"url":"https://lda.gov/api/v1/clients/203728/","client_id":48,"name":"THERMO FISHER SCIENTIFIC INC","general_description":"Scientific product and technology company.","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-11-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act PREEMPT Act (H.R. 9061) to promote the appropriate use of advanced preeclampsia biomarker testing as part of the Medicaid program. Seeking Senate companion legislation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72006,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"KEVIN","last_name":"BRENNAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}